UA106465C2 - Oxyntomodulin peptide analogue - Google Patents
Oxyntomodulin peptide analogueInfo
- Publication number
- UA106465C2 UA106465C2 UAA201207075A UAA201207075A UA106465C2 UA 106465 C2 UA106465 C2 UA 106465C2 UA A201207075 A UAA201207075 A UA A201207075A UA A201207075 A UAA201207075 A UA A201207075A UA 106465 C2 UA106465 C2 UA 106465C2
- Authority
- UA
- Ukraine
- Prior art keywords
- peptide analogue
- oxyntomodulin peptide
- oxyntomodulin
- analogue
- obesity
- Prior art date
Links
- 101800001388 Oxyntomodulin Proteins 0.000 title abstract 2
- 208000008589 Obesity Diseases 0.000 abstract 1
- 206010012601 diabetes mellitus Diseases 0.000 abstract 1
- 235000020824 obesity Nutrition 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/575—Hormones
- C07K14/605—Glucagons
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- Biophysics (AREA)
- Gastroenterology & Hepatology (AREA)
- Zoology (AREA)
- Biochemistry (AREA)
- Toxicology (AREA)
- General Health & Medical Sciences (AREA)
- Genetics & Genomics (AREA)
- Medicinal Chemistry (AREA)
- Molecular Biology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Endocrinology (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Abstract
The present invention provides an Oxyntomodulin peptide analogue useful in the treatment of diabetes and/or obesity.
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US28888809P | 2009-12-22 | 2009-12-22 | |
| PCT/US2010/060390 WO2011087672A1 (en) | 2009-12-22 | 2010-12-15 | Oxyntomodulin peptide analogue |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| UA106465C2 true UA106465C2 (en) | 2014-08-26 |
Family
ID=52681863
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| UAA201207075A UA106465C2 (en) | 2009-12-22 | 2010-12-15 | Oxyntomodulin peptide analogue |
Country Status (1)
| Country | Link |
|---|---|
| UA (1) | UA106465C2 (en) |
-
2010
- 2010-12-15 UA UAA201207075A patent/UA106465C2/en unknown
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| TN2012000302A1 (en) | Oxyntomodulin peptide analogue | |
| TN2012000303A1 (en) | Oxyntomodulin peptide analogue | |
| GEP20146056B (en) | Acylated glucagon analogues | |
| UA104605C2 (en) | Glucagon analogues | |
| MY158325A (en) | Multitype peptide compositions and methods for treatment or prevention of human papillpmavirus infection | |
| GB2465677B (en) | Non-systemic delivery of satiogens for use in the treatment of obesity and/or diabetes | |
| MX2012001346A (en) | Modified factor ix polypeptides and uses thereof. | |
| IL210810B (en) | Peptides for the treatment of pain and/or inflammation | |
| MX2010005317A (en) | Modified insulin polypeptides and their uses. | |
| JO3635B1 (en) | Solid pharmaceutical compositions and processes for their production | |
| AU2007221366A8 (en) | Oxyntomodulin derivatives | |
| MX2010006823A (en) | Methods for the treatment of gout. | |
| MX2010008632A (en) | Modified leptin polypeptides and their uses. | |
| IL193996A0 (en) | Neuromedin u receptor agonists and uses thereof | |
| IL188019A0 (en) | Novel peptides for use in the treatment of obesity | |
| MX2012009748A (en) | Use of transforming growth factor - beta 1 (tgf-î²1) inhibitor peptides for the treatment of corneal fibrosis and/or haze. | |
| IN2012DN05147A (en) | ||
| WO2009128867A3 (en) | Recombinant biologically contained filovirus | |
| WO2010039461A3 (en) | Methods for synthesis and uses of inhibitors of ghrelin o-acyltransferase as potential therapeutic agents for obesity and diabetes | |
| MX2010002950A (en) | Methods and compositions for detection of ehrlichia chaffeensis (vlpt). | |
| MX2010005915A (en) | Phenyl-oxetanyl-derivatives. | |
| IN2012DN00928A (en) | ||
| UA106465C2 (en) | Oxyntomodulin peptide analogue | |
| PH12012501264A1 (en) | Oxyntomodulin peptide analogue | |
| PL1792626T3 (en) | Treatment of obesity with alpha-MSH mimetibodies |